IGF1R and liver cancer: Similar results were obtained from knockdown experiments in another liver cancer cell line, HuH7 (Figure 4B), indicating that E-Syt1 contributes to the activation of IGF1R-Erk1/2 signaling in GPC3-positive liver cancer cells.